Drug Shortage Report for INNOHEP

Last updated on 2019-12-25 History
Report ID 89701
Drug Identification Number 02231478
Brand name INNOHEP
Common or Proper name Tinzaparin Sodium
Company Name LEO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TINZAPARIN SODIUM
Strength(s) 20000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 10 x 0.5mL syringe
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-07-19
Actual start date
Estimated end date 2020-01-15
Actual end date 2019-12-24
Shortage status Resolved
Updated date 2019-12-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3389 STEELES AVENUE EAST, SUITE 110
TORONTO, ONTARIO
CANADA M2H 3S8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-12-25 English Compare
v17 2019-12-24 French Compare
v16 2019-12-24 English Compare
v15 2019-11-15 French Compare
v14 2019-11-15 English Compare
v13 2019-11-12 French Compare
v12 2019-11-12 English Compare
v11 2019-10-17 French Compare
v10 2019-10-17 English Compare
v9 2019-08-28 French Compare
v8 2019-08-28 English Compare
v7 2019-08-28 French Compare
v6 2019-08-28 English Compare
v5 2019-08-28 English Compare
v4 2019-08-28 English Compare
v3 2019-07-20 English Compare
v2 2019-07-19 French Compare
v1 2019-07-19 English Compare

Showing 1 to 18 of 18